» Articles » PMID: 23524656

Vγ9Vδ2-T Lymphocytes Have Impaired Antiviral Function in Small-for-gestational-age and Preterm Neonates

Overview
Date 2013 Mar 26
PMID 23524656
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Preterm and small-for-gestational-age (SGA) neonates are vulnerable groups that are susceptible to various microbial infections. Vγ9Vδ2-T cells are critical components of the host immune system and have been demonstrated to play an important role in the defense against viral infection in adults. However, the characteristics of Vγ9Vδ2-T cells in children, especially the preterm and SGA populations, are poorly understood. Here, we examined the frequency and antiviral function of Vγ9Vδ2-T cells in neonates, including preterm, SGA and full-term babies. When compared to adults, neonates had a significantly lower percentage of Vγ9Vδ2-T cells in the blood. Upon influenza virus stimulation, neonatal Vγ9Vδ2-T cells, especially from preterm and SGA babies, showed markedly decreased and delayed antiviral cytokine responses than those of adults. In addition, the antiviral responses of neonatal Vγ9Vδ2-T cells were positively correlated with gestational age and birth weight. Finally, a weaker expansion of Vγ9Vδ2-T cells by isopentenyl pyrophosphate (IPP) was shown in neonates than the expansion in adults. Our data suggest that the depressed antiviral activity and decreased frequency of Vγ9Vδ2-T cells may likely account for the high susceptibility to microbial infection in neonates, particularly in preterm and SGA babies. Improving Vγ9Vδ2-T-cell function of neonates may provide a new way to defend against virus infection.

Citing Articles

The effect of intrauterine growth restriction on the developing pancreatic immune system.

Golden T, Garifallou J, Conine C, Simmons R bioRxiv. 2024; .

PMID: 39386426 PMC: 11463653. DOI: 10.1101/2024.09.19.613902.


Systemic immune markers and infection risk in preterm infants fed human milk fortified with bovine colostrum or conventional fortifier, a secondary analysis of the FortiColos trial.

Baek O, Muk T, Aunsholt L, Zachariasen G, Sangild P, Nguyen D Infection. 2024; 52(6):2315-2324.

PMID: 38775927 PMC: 11621174. DOI: 10.1007/s15010-024-02280-3.


Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes.

Mu X, Xiang Z, Xu Y, He J, Lu J, Chen Y Cell Mol Immunol. 2022; 19(8):944-956.

PMID: 35821253 PMC: 9338301. DOI: 10.1038/s41423-022-00894-x.


Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.

Wang X, Zhang Y, Mu X, Tu C, Chung Y, Tsao S J Immunother Cancer. 2022; 10(2).

PMID: 35105688 PMC: 8808451. DOI: 10.1136/jitc-2021-003832.


NKG2D as a Cell Surface Marker on γδ-T Cells for Predicting Pregnancy Outcomes in Patients With Unexplained Repeated Implantation Failure.

Huang C, Xiang Z, Zhang Y, Li Y, Xu J, Zhang H Front Immunol. 2021; 12:631077.

PMID: 33777016 PMC: 7988228. DOI: 10.3389/fimmu.2021.631077.


References
1.
Lappalainen M, Roponen M, Pekkanen J, Huttunen K, Hirvonen M . Maturation of cytokine-producing capacity from birth to 1 yr of age. Pediatr Allergy Immunol. 2009; 20(8):714-25. DOI: 10.1111/j.1399-3038.2009.00865.x. View

2.
Beetz S, Wesch D, Marischen L, Welte S, Oberg H, Kabelitz D . Innate immune functions of human gammadelta T cells. Immunobiology. 2008; 213(3-4):173-82. DOI: 10.1016/j.imbio.2007.10.006. View

3.
Tu W, Zheng J, Liu Y, Sia S, Liu M, Qin G . The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice. J Exp Med. 2011; 208(7):1511-22. PMC: 3135369. DOI: 10.1084/jem.20110226. View

4.
Zhou J, Kang N, Cui L, Ba D, He W . Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies. Cell Mol Immunol. 2011; 9(1):34-44. PMC: 4002925. DOI: 10.1038/cmi.2011.16. View

5.
Giannoni E, Guignard L, Reymond M, Perreau M, Roth-Kleiner M, Calandra T . Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns. Infect Immun. 2011; 79(7):2690-8. PMC: 3191988. DOI: 10.1128/IAI.00076-11. View